Orally administration of 50 mg ipragliflozin once a day, pre or post breakfast for 24 weeks

2 trials

Sponsors

Japan Community Health care Organization Kanazawa Hospital, Imamura clinic

Conditions

Type 2 diabetes

Unknown Phase

Investigation of the efficacy and safety of ipragliflozin combination therapy in case of insufficient glycemic control by DPP-4 inhibitors

Active, not recruitingJPRN-UMIN000014790

Japan Community Health care Organization Kanazawa HospitalType 2 diabetes

Start: 2014-08-11Target: 30Updated: 2026-06-29

A study on the efficacy of combination therapy of insulin and ipragliflozin in patients with type 2 diabetes

Active, not recruitingJPRN-UMIN000014798

Imamura clinicType 2 diabetes

Start: 2014-08-08Target: 15Updated: 2026-06-29